CIK 0000320017
- Non-accelerated filer
- Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222343568
- Phone
- +1 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-08 | Mazzo David J Chief Executive Officer | Shares withheld for taxes | −4,726 | $1.60 | $8K | 192,274 |
| 2020-11-01 | Whitaker Anne Clem Director | Grant or award | +79,470 | $1.51 | $120K | 79,470 |
| 2020-09-09 | Davidson Michael H. Director | Purchase | +55,525 | $1.80 | $100K | 106,588 |
| 2020-07-28 | Davidson Michael H. Director | Grant or award | +51,063 | $2.35 | $120K | 51,063 |
| 2020-01-14 | LOSORDO DOUGLAS W See Remarks | Shares withheld for taxes | −2,190 | $3.38 | $7K | 130,406 |
| 2020-01-14 | Talamo Joseph SVP and CFO | Shares withheld for taxes | −2,190 | $3.38 | $7K | 59,644 |
| 2020-01-14 | Mazzo David J Chief Executive Officer | Shares withheld for taxes | −6,382 | $3.38 | $22K | 186,382 |
| 2020-01-13 | LOSORDO DOUGLAS W See Remarks | Grant or award | +19,000 | 135,197 | ||
| 2020-01-13 | LOSORDO DOUGLAS W See Remarks | Shares withheld for taxes | −2,601 | $3.28 | $9K | 132,596 |
| 2020-01-13 | LOSORDO DOUGLAS W See Remarks | Grant or award · Stock Options (Right to Buy) | +29,000 | 29,000 | ||
| 2020-01-13 | Talamo Joseph SVP and CFO | Grant or award | +19,000 | 64,435 | ||
| 2020-01-13 | Talamo Joseph SVP and CFO | Shares withheld for taxes | −2,601 | $3.28 | $9K | 61,834 |
| 2020-01-13 | Talamo Joseph SVP and CFO | Grant or award · Stock Options (Right to Buy) | +29,000 | 29,000 | ||
| 2020-01-13 | Mazzo David J Chief Executive Officer | Grant or award | +46,000 | 199,010 | ||
| 2020-01-13 | Mazzo David J Chief Executive Officer | Shares withheld for taxes | −6,246 | $3.28 | $20K | 192,764 |
| 2020-01-13 | Mazzo David J Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +69,000 | 69,000 | ||
| 2020-01-13 | Schwalm Cynthia Director | Grant or award | +18,292 | $3.28 | $60K | 42,682 |
| 2020-01-13 | BROWN GREGORY B Director | Grant or award | +18,292 | $3.28 | $60K | 45,875 |
| 2020-01-13 | TRABER PETER G Director | Grant or award | +18,292 | $3.28 | $60K | 46,025 |
| 2020-01-13 | KLOSK STEVEN M Director | Grant or award | +18,292 | $3.28 | $60K | 48,225 |
Page 8 of 18 · 345 trades